Novo Nordisk shares up as Wegovy gets US nod for liver treatment | REUTERS

Shares in Novo Nordisk rose as much as 5% at opening after the US FDA granted accelerated approval for Wegovy to treat metabolic dysfunction-associated steatohepatitis, or MASH. #novonordisk #wegovyweightloss #wegovy #News #Reuters #Newsfeed Read the story here: https://reut.rs/47FtT1U 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en